G

Genezen Tech Stack

Gene therapy CDMO specializing in viral vector manufacturing at scale

Biotechnology Research Lexington, Massachusetts 201–500 employees Founded 2014 Privately Held

Genezen manufactures viral vectors (AAV, lentiviral, retroviral) for gene and cell therapy developers. The hiring mix—skewed toward engineering, quality, and manufacturing roles with accelerating velocity—reflects active scaling across production platforms. Current projects span downstream processing (50L systems), analytical method development and tech transfer, and LIMS/ELN implementation, signaling infrastructure build-out to support gmp scale-up and process robustness as they move programs toward pivotal trials.

Tech Stack 12 technologies

Core StackHPLC CAD LIMS ddPCR qPCR SDS-PAGE CMMS Word Excel Outlook Adobe Acrobat Veeva

What Genezen Is Building

◆Challenges

Minimizing risk during gmp scale-up
Scalable viral vector production platform
Process robustness improvement
Method troubleshooting
Supply chain issues
Audit readiness
Retaining talent
Attracting top talent
Quality and cost management
Short term production plan issues

▲Active Projects

Scalable viral vector production platform
Downstream vector platform 50l
Single-use system design and implementation
Method development and qualification for aav vector characterization
Tech transfer of analytical methods from clients to ad and qc labs
Implementation of lims/eln for electronic record keeping
Process transfer to manufacturing
Annual performance review process
Employee survey action planning
Next generation analytical procedures for viral vector testing

Hiring Activity

Accelerating20 roles · 10 in 30d

Department

Engineering

5

Quality

5

Manufacturing

4

Ops

3

Research

2

HR

1

Seniority

Senior

7

Junior

5

Mid

5

Lead

2

Principal

1

Company intelligence

Find more companies like Genezen by tech stack, pain points and active projects

Get started free

About Genezen

Genezen is a contract development and manufacturing organization (CDMO) for viral vectors used in gene and cell therapies. Founded in 2014, the company operates two manufacturing sites—one in Lexington, Massachusetts (holding FDA, EMA, Health Canada, and MFDS Korea licenses and currently producing a commercial viral vector product) and one in Indianapolis, Indiana (supporting cGMP manufacturing for a program entering pivotal clinical trials). Genezen serves innovator organizations across all stage and size, from early-stage to established companies, and maintains a technical stack anchored in analytical instrumentation (HPLC, qPCR, ddPCR, SDS-PAGE, LIMS, Veeva) alongside traditional lab and manufacturing systems.

HeadquartersLexington, Massachusetts

Company Size201–500 employees

Founded2014

Hiring MarketsUnited States

Frequently Asked Questions

What does Genezen manufacture?

Genezen manufactures viral vectors including AAV, lentiviral, and retroviral modalities for gene and cell therapy applications. The company holds regulatory licenses from the FDA, EMA, Health Canada, and MFDS Korea and operates cGMP manufacturing facilities.

Where are Genezen's manufacturing facilities located?

Genezen operates two sites: Lexington, Massachusetts (holding multiple global regulatory licenses and producing commercial viral vector products) and Indianapolis, Indiana (supporting cGMP manufacturing for programs entering pivotal clinical trials).